MMWR Morb Mortal Wkly Rep. 2022 Aug 26;71(34):1085-1091. doi: 10.15585/mmwr.mm7134a3.
Beginning the week of March 20–26, 2022, the Omicron BA.2 variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating variant in the United States, accounting for >50% of sequenced isolates.* Data from the COVID-19–Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to describe recent COVID-19–associated hospitalization rates among adults aged ≥18 years during the period coinciding with BA.2 predominance (BA.2 period [Omicron BA.2 and BA.2.12.1; March 20–May 31, 2022]). Weekly hospitalization rates (hospitalizations per 100,000 population) among adults aged ≥65 years increased threefold, from 6.9 (week ending April 2, 2022) to 27.6 (week ending May 28, 2022); hospitalization rates in adults aged 18–49 and 50–64 years both increased 1.7-fold during the same time interval. Hospitalization rates among unvaccinated adults were 3.4 times as high as those among vaccinated adults. Among hospitalized nonpregnant patients in this same period, 39.1% had received a primary vaccination series and 1 booster or additional dose; 5.0% had received a primary series and ≥2 boosters or additional doses. All adults should stay up to date† with COVID-19 vaccination, and multiple nonpharmaceutical and medical prevention measures should be used to protect those at high risk for severe COVID-19 illness, irrespective of vaccination status§ (1). Beginning the week of March 20–26, 2022, the Omicron BA.2 variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating variant in the United States, accounting for >50% of sequenced isolates.* Data from the COVID-19–Associated Hospitalization Surveillance Network (COVID-NET) were analyzed to describe recent COVID-19–associated hospitalization rates among adults aged ≥18 years during the period coinciding with BA.2 predominance (BA.2 period [Omicron BA.2 and BA.2.12.1; March 20–May 31, 2022]). Weekly hospitalization rates (hospitalizations per 100,000 population) among adults aged ≥65 years increased threefold, from 6.9 (week ending April 2, 2022) to 27.6 (week ending May 28, 2022); hospitalization rates in adults aged 18–49 and 50–64 years both increased 1.7-fold during the same time interval. Hospitalization rates among unvaccinated adults were 3.4 times as high as those among vaccinated adults. Among hospitalized nonpregnant patients in this same period, 39.1% had received a primary vaccination series and 1 booster or additional dose; 5.0% had received a primary series and ≥2 boosters or additional doses. All adults should stay up to date† with COVID-19 vaccination, and multiple nonpharmaceutical and medical prevention measures should be used to protect those at high risk for severe COVID-19 illness, irrespective of vaccination status§ (1).
从 2022 年 3 月 20 日至 26 日这一周开始,导致 COVID-19 的 SARS-CoV-2 病毒的奥密克戎 BA.2 变体成为美国主要传播的变体,其测序分离株占比超过 50%。*利用 COVID-19 相关住院监测网络(COVID-NET)的数据,对 2022 年 3 月 20 日至 5 月 31 日期间与 BA.2 流行期间(奥密克戎 BA.2 和 BA.2.12.1;2022 年 3 月 20 日至 5 月 31 日)相符的≥18 岁成年人的 COVID-19 相关住院率进行了描述。≥65 岁成年人的每周住院率(每 10 万人的住院人数)增加了三倍,从 6.9(2022 年 4 月 2 日结束的一周)增加到 27.6(2022 年 5 月 28 日结束的一周);在同一时期,18-49 岁和 50-64 岁成年人的住院率均增加了 1.7 倍。未接种疫苗成年人的住院率是接种疫苗成年人的 3.4 倍。在同期住院的非孕妇患者中,39.1%的人已接种初级疫苗系列和 1 次加强针或额外剂量;5.0%的人已接种初级系列和≥2 次加强针或额外剂量。所有成年人都应及时更新† COVID-19 疫苗接种,无论其疫苗接种状况§(1)如何,都应使用多种非药物和医疗预防措施来保护那些有罹患严重 COVID-19 疾病风险的人。